Literature DB >> 18257070

Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse.

Wataru Satoh1, Makoto Matsuyama, Hiromasa Takemura, Shinichi Aizawa, Akihiko Shimono.   

Abstract

Sfrp is a secreted Wnt antagonist that directly interacts with Wnt ligand. We show here that inactivation of Sfrp1, Sfrp2, and Sfrp5 leads to fused somites formation in early-somite mouse embryos, simultaneously resulting in defective convergent extension (CE), which causes severe shortening of the anteroposterior axis. These observations indicate the redundant roles of Sfrp1, Sfrp2, and Sfrp5 in early trunk formation. The roles of the Sfrps were genetically distinguished in terms of the regulation of Wnt pathways. Genetic analysis combining Sfrps mutants and Loop-tail mice revealed the involvement of Sfrps in CE through the regulation of the planar cell polarity pathway. Furthermore, Dkk1-deficient embryos carrying Sfrp1 homozygous and Sfrp2 heterozygous mutations display irregular somites and indistinct intersomitic boundaries, which indicates that Sfrps-mediated inhibition of the Wnt/beta-catenin pathway is necessary for somitogenesis. Our results suggest that Sfrps regulation of the canonical and noncanonical pathways is essential for proper trunk formation. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257070     DOI: 10.1002/dvg.20369

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  55 in total

1.  SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.

Authors:  Julianna Kele; Emma R Andersson; J Carlos Villaescusa; Lukas Cajanek; Clare L Parish; Sonia Bonilla; Enrique M Toledo; Vitezslav Bryja; Jeffrey S Rubin; Akihiko Shimono; Ernest Arenas
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

2.  Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.

Authors:  Hiroyuki Mori; Tyler C Prestwich; Michael A Reid; Kenneth A Longo; Isabelle Gerin; William P Cawthorn; Vedrana S Susulic; Venkatesh Krishnan; Andy Greenfield; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

3.  shRNA targeting SFRP2 promotes the apoptosis of hypertrophic scar fibroblast.

Authors:  Zhicheng Sun; Shirong Li; Chuan Cao; Jun Wu; Bing Ma; Vu Tran
Journal:  Mol Cell Biochem       Date:  2011-02-02       Impact factor: 3.396

Review 4.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

Review 5.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

6.  Ift88 regulates Hedgehog signaling, Sfrp5 expression, and β-catenin activity in post-natal growth plate.

Authors:  Ching-Fang Chang; Rosa Serra
Journal:  J Orthop Res       Date:  2012-10-03       Impact factor: 3.494

7.  Bmp inhibition is necessary for post-gastrulation patterning and morphogenesis of the zebrafish tailbud.

Authors:  Richard H Row; David Kimelman
Journal:  Dev Biol       Date:  2009-02-21       Impact factor: 3.582

8.  Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling.

Authors:  Yan Li; Scott A Rankin; Débora Sinner; Alan P Kenny; Paul A Krieg; Aaron M Zorn
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

9.  Myocilin is a modulator of Wnt signaling.

Authors:  Heung-Sun Kwon; Hee-Sheung Lee; Yun Ji; Jeffrey S Rubin; Stanislav I Tomarev
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 10.  Genetics of human neural tube defects.

Authors:  Nicholas D E Greene; Philip Stanier; Andrew J Copp
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.